Barclays PLC Publication of Suppl.Prospcts (1602C)
14 June 2019 - 1:30AM
UK Regulatory
TIDMBARC
RNS Number : 1602C
Barclays PLC
13 June 2019
Publication of Prospectus Supplement
The following prospectus supplement (the "Prospectus
Supplement") is available for viewing:
Prospectus Supplement dated 6 June 2019 in connection with the
issue of GBP1,000,000,000 7.125% Fixed Rate Resetting Perpetual
Subordinated Contingent Convertible Securities (Callable June 15,
2025 and Every Five Years Thereafter) (the "Securities")
incorporating the Prospectus dated April 6, 2018 relating to the
Securities (the "Base Prospectus").
Please read the disclaimer below "Disclaimer - Intended
Addressees" before attempting to access this service, as your right
to do so is conditional upon complying with the requirements set
out below.
To view the Prospectus Supplement, please paste the following
URL into the address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/1602C_1-2019-6-13.pdf
A copy of the above documents have been submitted to the
National Storage Mechanism and will shortly be available for
inspection at: http://www.morningstar.co.uk/uk/NSM
For further information, please contact:
Barclays Treasury
1 Churchill Place
Canary Wharf
London E14 5HP
DISCLAIMER - INTENDED ADDRESSEES
IMPORTANT: You must read the following before continuing: The
following applies to the Prospectus Supplement available by
clicking on the link above, and you are therefore advised to read
this carefully before reading, accessing or making any other use of
the Prospectus Supplement. In accessing the Prospectus Supplement,
you agree to be bound by the following terms and conditions,
including any modifications to them, any time you receive any
information from us as a result of such access.
The Prospectus Supplement referred to above must be read in
conjunction with the Base Prospectus.
THE PROSPECTUS SUPPLEMENT MAY NOT BE FORWARDED OR DISTRIBUTED
OTHER THAN AS PROVIDED BELOW AND MAY NOT BE REPRODUCED IN ANY
MANNER WHATSOEVER. ANY FORWARDING, DISTRIBUTION OR REPRODUCTION OF
THE PROSPECTUS SUPPLEMENT IN WHOLE OR IN PART IS PROHIBITED.
FAILURE TO COMPLY WITH THIS NOTICE MAY RESULT IN A VIOLATION OF THE
U.S. SECURITIES ACT OF 1933, AS AMENDED, OR THE APPLICABLE LAWS OF
OTHER JURISDICTIONS.
NOTHING IN THIS ELECTRONIC PUBLICATION CONSTITUTES AN OFFER OF
SECURITIES FOR SALE IN ANY JURISDICTION. ANY SECURITIES ISSUED OR
TO BE ISSUED PURSUANT TO THE PROSPECTUS SUPPLEMENT HAVE NOT BEEN
AND WILL NOT BE REGISTERED UNDER THE SECURITIES LAWS OF ANY
JURISDICTION OTHER THAN THE UNITED STATES.
Please note that the information contained in the Prospectus
Supplement and the Base Prospectus referred to above may be
addressed to and/or targeted at persons who are residents of
particular countries (specified in the Prospectus Supplement and
the Base Prospectus) only and is not intended for use and should
not be relied upon by any person outside these countries and/or to
whom the offer contained in the Prospectus Supplement and/or the
Base Prospectus is not addressed. Prior to relying on the
information contained in the Prospectus Supplement and/or the Base
Prospectus you must ascertain from the Prospectus Supplement and
the Base Prospectus whether or not you are part of the intended
addressees of the information contained therein.
You are reminded that the Prospectus Supplement has been made
available to you on the basis that you are a person into whose
possession the Prospectus Supplement may be lawfully delivered in
accordance with the laws of the jurisdiction in which you are
located and you may not, nor are you authorised to, deliver the
Prospectus Supplement to any other person.
The Prospectus Supplement does not constitute, and may not be
used in connection with, an offer or solicitation in any place
where offers or solicitations are not permitted by law. If a
jurisdiction requires that the offering be made by a licensed
broker or dealer and the underwriters or any affiliate of the
underwriters is a licensed broker or dealer in that jurisdiction,
the offering shall be deemed to be made by the underwriters or such
affiliate on behalf of the issuer in such jurisdiction. Under no
circumstances shall the Prospectus Supplement constitute an offer
to sell, or the solicitation of an offer to buy, nor shall there be
any sale of any Securities issued or to be issued pursuant to the
Prospectus Supplement, in any jurisdiction in which such offer,
solicitation or sale would be unlawful.
The Prospectus Supplement has been made available to you in an
electronic form. You are reminded that documents transmitted via
this medium may be altered or changed during the process of
electronic transmission and consequently none of the issuer, its
advisers nor any person who controls any of them nor any director,
officer, employee nor agent of it or affiliate of any such person
accepts any liability or responsibility whatsoever in respect of
any difference between the Prospectus Supplement made available to
you in electronic format and the hard copy versions available to
you on request from the issuer.
Your right to access this service is conditional upon complying
with the above requirement.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
PSPUOSSRKVANAAR
(END) Dow Jones Newswires
June 13, 2019 11:30 ET (15:30 GMT)
Barclays (LSE:BARC)
Historical Stock Chart
From Apr 2024 to May 2024
Barclays (LSE:BARC)
Historical Stock Chart
From May 2023 to May 2024